Renal Week 2009 - Hyperphosphatemia - Renal and Urology News

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Renal Week 2009 Hyperphosphatemia Coverage

Normal Phosphate Levels May Predict CKD Progression

Jody A. Charnow November 01, 2009

Serum phosphate within the normal range is a strong predictor of CKD progression, according to Italian researchers who presented a study at ASN's Renal Week 2009.

Tablet Burden Lowest with Lanthanum Carbonate

Jody A. Charnow November 01, 2009

CKD patients who used lanthanum carbonate to manage hyperphosphatemia had a lower mean tablet burden compared with those who took sevelamer hydrochloride or calcium acetate, according to researchers who presented a study at ASN's Renal Week 2009.

Hemodialysis Patients Benefit from Residual Kidney Function

Jody A. Charnow November 01, 2009

Hemodialysis patients who have residual kidney function have lower serum phosphate levels and use less phosphate binders than those without RKF, according to a study presented at ASN's Renal Week 2009.

Hyperphosphatemia Afflicts Nearly Three-Fourths of HD Patients

Jody A. Charnow November 01, 2009

Researchers who reviewed data from about 60,000 hemodialysis patients found that 73% of them experienced hyperphosphatemia according to a study presented at ASN's Renal Week 2009.

Nocturnal Hemodialysis Improves Protein and Phosphorus Status

Jody A. Charnow October 31, 2009

Patients who undergo in-center nocturnal hemodialysis have improved protein and phosphorus status compared with those treated with in-center conventional hemodialysis, according to a study that was presented at ASN's Renal Week 2009.

Sevelamer May Have Benefits Beyond Phosphorus Lowering

Jody A. Charnow October 31, 2009

Sevelamer treatment for hyperphosphatemia in dialysis patients may provide benefits in addition to lowering phosphorus, according to a study conducted in Taiwan that was presented at ASN's Renal Week 2009.

Higher Dietary Phosphorus Intake Raises Mortality Risk

Jody A. Charnow October 31, 2009

Higher dietary phosphorus intake is associated with increased mortality in patients on maintenance hemodialysis, data show.

Phosphate Knowledge Lacking Among Dialysis Patients

Jody A. Charnow October 31, 2009

Dialysis patients' understanding of issues related to phosphate control needs improvement, according to a study presented at the American Society of Nephrology's Renal Week conference.

Higher Mortality Linked to Elevated Alkaline Phosphatase in CKD

Jody A. Charnow October 30, 2009

Elevated serum alkaline phosphatase levels—which reflect increased bone turnover in CKD—are associated with increased mortality in patients with non-dialysis CKD, researchers have concluded in a study that was presented at ASN's Renal Week 2009.

Phosphate Levels Higher in African-American CKD Patients

Jody A. Charnow October 30, 2009

Among CKD patients, African Americans have significantly higher serum phosphate levels than whites, researchers have found, according to a study presented at ASN's Renal Week 2009.

Phosphate Binders May Lower Death Risk

Jody A. Charnow October 30, 2009

Phosphate binder use is associated with a reduced death risk and slower progression of renal disease in non-dialysis CKD patients, according to investigators at ASN's Renal Week 2009.

Drugs Not Equal in Phosphorus Lowering

Jody A. Charnow October 30, 2009

Lanthanum carbonate treatment achieved greater reductions in serum phosphorus than did sevelamer hydrochloride in a study of hemodialysis patients with elevated serum phosphorus that was presented at ASN's Renal Week 2009.

Study: Combo Could Be a Promising New Option for Hyperphosphatemia

Jody A. Charnow October 29, 2009

Combination tablets containing calcium acetate and magnesium carbonate (CaMg) may be at least as effective as sevelamer hydrochloride tablets in lowering serum phosphorus, a study found.

Ferric Citrate Works as Well as Other Phosphate Binders

Jody A. Charnow October 29, 2009

Ferric citrate is at least as potent as other phosphate binders and it raises serum sodium bicarbonate levels, according to a pilot study of hemodialysis (HD) patients requiring high doses of phosphate binders.

Vitamin D Plus a Phosphorus Binder Improves Survival in Dialysis Patients

Jody A. Charnow October 29, 2009

A study of Japanese dialysis patients demonstrated that a combination of oral vitamin D and a phosphorus binder is associated with lower mortality.

Higher Phosphorus Levels, Atherosclerosis Linked

Jody A. Charnow October 29, 2009

Higher phosphorus levels are associated with peripheral atherosclerosis and arterial stiffness, independent of traditional risk factors for cardiovascular disease (CVD), according to a study.